Association between lifetime cigarette smoking and Lewy body accumulation

Brain Pathology

Volumn 20, Issue 2, 2010, Pages 412-418

  Tsuang, Debby ^a,c   Larson, Eric B ^a,b   Li, Ge ^a,c   Shofer, Jane B ^a   Montine, Kathleen S ^a   Thompson, Mary Lou ^a   Sonnen, Joshua A ^a   Crane, Paul K ^a   Leverenz, James B ^a,c   Montine, Thomas J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Alzheimer's disease; Lewy body; Neuropathology; Smoking

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN REGION; CIGARETTE SMOKING; CLINICAL TRIAL; COMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LEWY BODY; LIFESPAN; MALE; MORBIDITY; NEUROPATHOLOGY; OBSERVATIONAL STUDY; PARKINSON DISEASE; PROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; FEMALE; HUMANS; LEWY BODIES; MALE; PROBABILITY; PROSPECTIVE STUDIES; RISK; SMOKING; TIME FACTORS;

EID: 75949123145     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00296.x     Document Type: Article

References (24)

1. Anonymous (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for The Neuropathological Assessment of Alzheimer's disease. Neurobiol Aging 18 : S1 S2.
2. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82 : 239 259.
3. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318 : 121 134.
4. de Boor C (1978) A Practical Guide to Splines. Springer Verlag : Berlin.
5. Efron B, Tibshirani R (1986) Bootstrap methods for standard errors, confidence intervals, and other measured of statistical accuracy. Stat Sci 1 : 54 75.
6. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51 : 745 752.
7. Hernan MA, Alonso A, Logroscino G (2008) Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology 19 : 448 450.
8. Hong DP, Fink AL, Uversky VN (2009) Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation? Biochim Biophys Acta 1794 : 282 290.
9. Kasten M, Chade A, Tanner CM (2007) Epidemiology of Parkinson's disease. Handb Clin Neurol 83 : 129 151.
10. Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ et al (2003) Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 62 : 1087 1095.
11. Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD et al (2002) Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 59 : 1737 1746.
12. Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB et al (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 18 : 220 224.
13. Lumley T, Kronmal R, Ma S (2006) Relative Risk Regression in Medical Research: Models, Contrasts, Estimators, and Algorithms. University of Washington : Seattle, WA.
14. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 : 1113 1124.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 : 939 944.
16. McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157 : 940 943.
17. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 : 479 486.
18. Ono K, Hirohata M, Yamada M (2007) Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases. Exp Neurol 205 : 414 424.
19. Quik M, O'Neill M, Perez XA (2007) Nicotine neuroprotection against nigrostriatal damage: importance of the animal model. Trends Pharmacol Sci 28 : 229 235.
20. Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA et al (2007) Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64 : 990 997.
21. Tan LC, Koh WP, Yuan JM, Wang R, Au WL, Tan JH et al (2008) Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. Am J Epidemiol 167 : 553 560.
22. Thacker EL, O'Reilly EJ, Weisskopf MG, Chen H, Schwarzschild MA, McCullough ML et al (2007) Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology 68 : 764 768.
23. Tsuang D, Simpson K, Larson EB, Peskind E, Kukull W, Bowen JB et al (2006) Predicting lewy body pathology in a community-based sample with clinical diagnosis of Alzheimer's disease. J Geriatr Psychiatry Neurol 19 : 195 201.
24. Zhao LP, Lipsitz S (1992) Designs and analysis of two-stage studies. Stat Med 11 : 769 782.